๐Ÿง Centiloid ๋ณ€ํ™˜ ๋ฐฉ๋ฒ•: ์•„๋ฐ€๋กœ์ด๋“œ PET SUVr์„ ํ‘œ์ค€ ๋‹จ์œ„๋กœ ๋ฐ”๊พธ๋Š” ์ดˆ๊ฐ„๋‹จ ๊ฐ€์ด๋“œ

๐Ÿง Centiloid ๋ณ€ํ™˜ ๋ฐฉ๋ฒ•: ์•„๋ฐ€๋กœ์ด๋“œ PET SUVr์„ ํ‘œ์ค€ ๋‹จ์œ„๋กœ ๋ฐ”๊พธ๋Š” ์ดˆ๊ฐ„๋‹จ ๊ฐ€์ด๋“œ


์•„๋ฐ€๋กœ์ด๋“œ PET ๊ฒ€์‚ฌ์—์„œ SUVr ๊ฐ’์„ ๋ฝ‘์•˜๋Š”๋ฐ, ๋ณ‘์›๋งˆ๋‹ค·์ถ”์ ์ž๋งˆ๋‹ค ๊ธฐ์ค€์ด ๋‹ฌ๋ผ์„œ ๋น„๊ต๊ฐ€ ์–ด๋ ต์ฃ ?
๊ทธ๋Ÿด ๋•Œ ๋“ฑ์žฅํ•˜๋Š” ๊ฒƒ์ด ๋ฐ”๋กœ Centiloid (์„ผํ‹ธ๋กœ์ด๋“œ) ๋‹จ์œ„์ž…๋‹ˆ๋‹ค.
Centiloid๋Š” ์ „ ์„ธ๊ณ„ ์•„๋ฐ€๋กœ์ด๋“œ PET ๊ฒฐ๊ณผ๋ฅผ ํ•˜๋‚˜์˜ ๊ณตํ†ต ์ฒ™๋„๋กœ ๋ณ€ํ™˜ํ•ด์ฃผ๋Š” ๊ตญ์ œ ํ‘œ์ค€์ด์—์š”.
์˜ค๋Š˜์€ ์ด Centiloid ๋ณ€ํ™˜ ๋ฐฉ๋ฒ•์„ ์ดˆ๋ณด์ž๋„ ๋”ฐ๋ผ ํ•  ์ˆ˜ ์žˆ๋„๋ก ๊ฐ€์žฅ ์‹ค์šฉ์ ์ด๊ณ  ์ตœ์‹  ๊ธฐ์ค€์œผ๋กœ ์ •๋ฆฌํ•ด ๋“œ๋ฆด๊ฒŒ์š”.
"๋‚ด SUVr์ด Centiloid๋กœ ๋ฐ”๋€Œ๋ฉด ๊ฐ‘์ž๊ธฐ ์—ฐ๊ตฌ ๋…ผ๋ฌธ ์ˆ˜์ค€์ด ๋˜๋Š” ๊ธฐ๋ถ„!"์ฒ˜๋Ÿผ ๋А๊ปด๋ณด์„ธ์š”.
[์—ฌ๊ธฐ์— ๊ทธ๋ฆผ ์‚ฝ์ž…: Centiloid ์Šค์ผ€์ผ ๊ทธ๋ž˜ํ”„ ์˜ˆ์‹œ. SUVr 0.82.0 ๋ฒ”์œ„์— Centiloid 0150์ด ํ‘œ์‹œ๋œ ์„ ํ˜• ๊ทธ๋ž˜ํ”„. "SUVr → Centiloid, ํ•œ ์ค„๋กœ ์—ฐ๊ฒฐ!" ์บก์…˜.][์—ฌ๊ธฐ์— ๊ทธ๋ฆผ ์‚ฝ์ž…: ๋‹ค์–‘ํ•œ ์•„๋ฐ€๋กœ์ด๋“œ ์ถ”์ ์ž(Florbetapir, Flutemetamol ๋“ฑ)์˜ Centiloid ๋ณ€ํ™˜ ๊ณต์‹ ๋น„๊ต ํ‘œ. "์ถ”์ ์ž๋งˆ๋‹ค ๊ณต์‹์ด ๋‹ค๋ฅด๋‹ค!" ์บก์…˜.]๋ชฉ์ฐจ
  1. Centiloid๋ž€ ๋ฌด์—‡์ธ๊ฐ€? ์™œ ํ•„์š”ํ•œ๊ฐ€?
  2. Centiloid ๋ณ€ํ™˜์˜ ๊ธฐ๋ณธ ์›๋ฆฌ
  3. ์ฃผ์š” ์•„๋ฐ€๋กœ์ด๋“œ ์ถ”์ ์ž๋ณ„ Centiloid ๋ณ€ํ™˜ ๊ณต์‹
  4. 3D Slicer์—์„œ SUVr ๊ตฌํ•œ ํ›„ Centiloid๋กœ ๋ณ€ํ™˜ํ•˜๋Š” ์‹ค์ „ ์ˆœ์„œ
  5. Centiloid ํ•ด์„ ๊ธฐ์ค€ (์ •์ƒ vs ์–‘์„ฑ vs ๊ณ ์œ„ํ—˜)
  6. ์ฃผ์˜์ ๊ณผ ํ”ํ•œ ์‹ค์ˆ˜ ํ”ผํ•˜๊ธฐ
  7. ์š”์•ฝ
  8. ํƒœ๊ทธ ๊ฒ€์ƒ‰
1. Centiloid๋ž€ ๋ฌด์—‡์ธ๊ฐ€? ์™œ ํ•„์š”ํ•œ๊ฐ€?Centiloid๋Š” Klunk et al. (2018)์ด ์ œ์•ˆํ•œ ๊ตญ์ œ ํ‘œ์ค€ ๋‹จ์œ„๋กœ,
๋ชจ๋“  ์•„๋ฐ€๋กœ์ด๋“œ PET ์ถ”์ ์ž์˜ ๊ฒฐ๊ณผ๋ฅผ ํ•˜๋‚˜์˜ ๊ณตํ†ต ์ฒ™๋„๋กœ ๋ฐ”๊ฟ”์ฃผ๋Š” ๋ฐฉ๋ฒ•์ž…๋‹ˆ๋‹ค.
์™œ ํ•„์š”ํ• ๊นŒ?
  • Florbetapir SUVr 1.2 = Flutemetamol SUVr 0.65 = Florbetaben SUVr 1.08
    → ์ถ”์ ์ž๋งˆ๋‹ค SUVr ๊ฐ’ ๋ฒ”์œ„๊ฐ€ ๋‹ฌ๋ผ์„œ ์ง์ ‘ ๋น„๊ต ๋ถˆ๊ฐ€๋Šฅ
  • Centiloid๋Š” ์ด๋ฅผ 0~100+ ์Šค์ผ€์ผ๋กœ ํ†ต์ผ → ์ „ ์„ธ๊ณ„ ์—ฐ๊ตฌ·์ž„์ƒ์—์„œ ๊ฐ™์€ ๊ธฐ์ค€ ์‚ฌ์šฉ ๊ฐ€๋Šฅ
Centiloid 0 = ์ Š์€ ์ •์ƒ์ธ ํ‰๊ท  (์•„๋ฐ€๋กœ์ด๋“œ ์—†์Œ)
Centiloid 20~25 = ์•„๋ฐ€๋กœ์ด๋“œ ์–‘์„ฑ ๊ฒฝ๊ณ„ (cut-off)
Centiloid 50 ์ด์ƒ = ์•Œ์ธ ํ•˜์ด๋จธ๋ณ‘ ๊ณ ํ™•๋ฅ 
2. Centiloid ๋ณ€ํ™˜์˜ ๊ธฐ๋ณธ ์›๋ฆฌ๋Œ€๋ถ€๋ถ„ ์„ ํ˜• ๋ณ€ํ™˜ ๊ณต์‹์„ ์‚ฌ์šฉํ•ฉ๋‹ˆ๋‹ค.๊ธฐ๋ณธ ๊ณต์‹ (๊ฐ€์žฅ ํ”ํ•œ ํ˜•ํƒœ):Centiloid = 100 × (SUVr - Young Control Mean) / (AD Mean - Young Control Mean)ํ•˜์ง€๋งŒ ๊ฐ ์ถ”์ ์ž๋งˆ๋‹ค Young Control Mean๊ณผ AD Mean ๊ฐ’์ด ๋‹ค๋ฅด๊ธฐ ๋•Œ๋ฌธ์—
์ถ”์ ์ž๋ณ„ ๊ณ ์œ  ๊ณต์‹์„ ์‚ฌ์šฉํ•ด์•ผ ํ•ฉ๋‹ˆ๋‹ค.
3. ์ฃผ์š” ์•„๋ฐ€๋กœ์ด๋“œ ์ถ”์ ์ž๋ณ„ Centiloid ๋ณ€ํ™˜ ๊ณต์‹(2024~2025๋…„ ์ตœ์‹  ๊ธฐ์ค€, ๋Œ€๋ถ€๋ถ„ ์†Œ๋‡Œ ํšŒ๋ฐฑ์งˆ ์ฐธ์กฐ)
์ถ”์ ์ž
์ƒํ’ˆ๋ช…
Centiloid ๋ณ€ํ™˜ ๊ณต์‹ (์†Œ๋‡Œ ๊ธฐ์ค€)
Cut-off (์–‘์„ฑ ๊ธฐ์ค€)
์ฐธ๊ณ  ๋ฌธํ—Œ
Florbetapir
Amyvid
CL = 183 × SUVr - 183
CL ≥ 20~25
Klunk 2018, ADNI
Flutemetamol
Vizamyl
CL = 121 × (SUVr - 0.64)
CL ≥ 20~25
FDA label 2023
Florbetaben
Neuraceq
CL = 196 × (SUVr - 0.95)
CL ≥ 20~25
FDA label 2024
NAV4694
(์—ฐ๊ตฌ์šฉ)
CL = 174 × SUVr - 174
CL ≥ 20~25
Rowe 2017
PiB (Pittsburgh Compound B)
(์—ฐ๊ตฌ์šฉ ํ‘œ์ค€)
CL = 100 × (SUVr - 1.0) / (2.0 - 1.0) ≈ 100 × (SUVr - 1.0)
CL ≥ 20~25
Klunk 2004
๊ฐ€์žฅ ๋งŽ์ด ์“ฐ์ด๋Š” ๊ณต์‹ TOP 3 (ํ•œ๊ตญ ๋ณ‘์› ๊ธฐ์ค€)
  1. Florbetapir: CL = 183 × SUVr - 183
  2. Flutemetamol: CL = 121 × (SUVr - 0.64)
  3. Florbetaben: CL = 196 × (SUVr - 0.95)
4. 3D Slicer์—์„œ SUVr ๊ตฌํ•œ ํ›„ Centiloid๋กœ ๋ณ€ํ™˜ํ•˜๋Š” ์‹ค์ „ ์ˆœ์„œ
  1. ์ด์ „ ๋‹จ๊ณ„์—์„œ ์–ป์€ SUVr ๊ฐ’ ๋ณต์‚ฌ (์˜ˆ: ํ›„๋‘์—ฝ SUVr = 1.38)
  2. ์‚ฌ์šฉํ•œ ์ถ”์ ์ž ํ™•์ธ (Amyvid? Vizamyl? Neuraceq?)
  3. ์œ„ ํ‘œ์—์„œ ํ•ด๋‹น ๊ณต์‹ ์„ ํƒ
  4. ๊ณ„์‚ฐ๊ธฐ ๋˜๋Š” Excel ์—ด๊ธฐ
    • ์˜ˆ์‹œ (Florbetapir ์‚ฌ์šฉ ์‹œ)
      → CL = 183 × 1.38 - 183 = 252.54 - 183 = 69.54
      → Centiloid 69.54 → ๋ช…๋ฐฑํ•œ ์•„๋ฐ€๋กœ์ด๋“œ ์–‘์„ฑ (๊ณ ์œ„ํ—˜)
  5. ๊ฒฐ๊ณผ ํ•ด์„
    • CL < 10~15 → ์Œ์„ฑ
    • CL 20~25 → ๊ฒฝ๊ณ„ (Gray Zone)
    • CL > 25~30 → ์–‘์„ฑ
    • CL > 50 → ๊ณ ๋ถ€ํ•˜ ์•„๋ฐ€๋กœ์ด๋“œ
5. Centiloid ํ•ด์„ ๊ธฐ์ค€ (์ •์ƒ vs ์–‘์„ฑ vs ๊ณ ์œ„ํ—˜)
  • CL 0~10: ์ Š์€ ์ •์ƒ์ธ ์ˆ˜์ค€ (์•„๋ฐ€๋กœ์ด๋“œ ๊ฑฐ์˜ ์—†์Œ)
  • CL 10~20: ๊ฒฝ๊ณ„ ์ €๋ถ€ํ•˜ (Gray Zone ํ•˜๋‹จ)
  • CL 20~25: ๋Œ€๋ถ€๋ถ„ ๊ธฐ๊ด€์˜ ์–‘์„ฑ Cut-off (์–‘์„ฑ ํŒ์ • ์‹œ์ž‘)
  • CL 25~50: ์ค‘๋“ฑ๋„ ์•„๋ฐ€๋กœ์ด๋“œ ์ถ•์ 
  • CL 50~100+: ๊ณ ๋ถ€ํ•˜ ์•„๋ฐ€๋กœ์ด๋“œ (์•Œ์ธ ํ•˜์ด๋จธ๋ณ‘ ํ™•๋ฅ  ๋งค์šฐ ๋†’์Œ)
์‹ค์ œ ์ž„์ƒ ์˜ˆ์‹œ
  • 68์„ธ ์—ฌ์„ฑ, ๊ธฐ์–ต๋ ฅ ์ €ํ•˜ → Florbetapir SUVr 1.42 → CL = 183 × 1.42 - 183 ≈ 77 → ๊ณ ๋ถ€ํ•˜ ์–‘์„ฑ → ์•Œ์ธ ํ•˜์ด๋จธ ์ง„๋‹จ ํ›„ ๋ ˆ์นด๋„ค๋ง™ ์ฒ˜๋ฐฉ ์‹œ์ž‘
์ฐธ์กฐ ์‚ฌ์ดํŠธ: Centiloid Project ๊ณต์‹
https://centiloidproject.org/
6. ์ฃผ์˜์ ๊ณผ ํ”ํ•œ ์‹ค์ˆ˜ ํ”ผํ•˜๊ธฐ
  1. ์ถ”์ ์ž๋ณ„ ๊ณต์‹ ๋‹ค๋ฆ„ – Amyvid ๊ณต์‹์„ Vizamyl์— ์“ฐ๋ฉด ์™„์ „ํžˆ ํ‹€๋ฆฐ ๊ฐ’ ๋‚˜์˜ด
  2. ์ฐธ์กฐ ์˜์—ญ ์ผ์น˜ ์—ฌ๋ถ€ – ์†Œ๋‡Œ ์ „์ฒด vs ์†Œ๋‡Œ ํšŒ๋ฐฑ์งˆ๋งŒ vs pons ๋“ฑ ๋‹ค๋ฅด๋ฉด ๊ฐ’ ๋‹ฌ๋ผ์ง
  3. ๋ถ€๋ถ„ ์ฒด์  ํšจ๊ณผ(PVE) ๋ณด์ • ์—ฌ๋ถ€ – ๋ณด์ •ํ•˜๋ฉด SUVr ๊ฐ’์ด ์•ฝ๊ฐ„ ๋‚ฎ์•„์งˆ ์ˆ˜ ์žˆ์Œ
  4. ์—ฐ๋ น·์ธ์ข… ๋ณด์ • – 70๋Œ€ ์ด์ƒ์€ CL 5~10 ์ •๋„ ๋†’๊ฒŒ ๋‚˜์˜ฌ ์ˆ˜ ์žˆ์Œ
  5. Gray Zone (CL 20~30)์€ ๋ฐ˜๋“œ์‹œ ์ž„์ƒ ์ฆ์ƒ๊ณผ ํ•จ๊ป˜ ํ•ด์„
์ฐธ์กฐ ์‚ฌ์ดํŠธ: EANM Amyloid PET Guidelines
https://www.eanm.org/publications/guidelines/
์š”์•ฝCentiloid ๋ณ€ํ™˜์€ ์ถ”์ ์ž๋ณ„ ๊ณต์‹์œผ๋กœ SUVr์„ ํ‘œ์ค€ํ™”ํ•˜๋Š” ๋ฐฉ๋ฒ•์ž…๋‹ˆ๋‹ค.
  • Florbetapir: CL = 183 × SUVr - 183
  • Flutemetamol: CL = 121 × (SUVr - 0.64)
  • Florbetaben: CL = 196 × (SUVr - 0.95)
    Cut-off๋Š” ๋Œ€๋ถ€๋ถ„ CL 20~25์—์„œ ์–‘์„ฑ ํŒ์ • ์‹œ์ž‘์ด์—์š”.
    3D Slicer๋กœ ๋ฝ‘์€ SUVr์„ ์ด ๊ณต์‹์— ๋„ฃ์œผ๋ฉด ์ „ ์„ธ๊ณ„์™€ ๊ฐ™์€ ๊ธฐ์ค€์œผ๋กœ ๋น„๊ต ๊ฐ€๋Šฅํ•ด์ง‘๋‹ˆ๋‹ค!
ํƒœ๊ทธ ๊ฒ€์ƒ‰#Centiloid #SUVr #์•„๋ฐ€๋กœ์ด๋“œPET #์•Œ์ธ ํ•˜์ด๋จธ #Florbetapir #Flutemetamol #Florbetaben #PET์ •๋Ÿ‰๋ถ„์„ #์˜๋ฃŒ์˜์ƒ #CutOff๊ฐ’Centiloid ๋ณ€ํ™˜ ์–ด๋ ค์›€? 3๋Œ€ ์ถ”์ ์ž ๊ณต์‹์œผ๋กœ ํ•œ ๋ฒˆ์— ํ•ด๊ฒฐ! ์ดˆ๋ณด์ž๋„ SUVr→Centiloid ์™„๋ฒฝ ์ดํ•ด, ์‹ ๋‚˜๋Š” ์—ฐ๊ตฌ·์ง„๋‹จ ๊ธฐ์จ! https://draft.blogger.com/ (blogspot.com: Centiloid ๋ณ€ํ™˜ ๊ณต์‹·Cut-off ์ƒ์„ธ ๋งค๋‰ด์–ผ – 150์ž ์ด๋‚ด ์„ค๋ช…)[^1]: “SUVr 1.38์„ Centiloid๋กœ ๋ฐ”๊พธ๋‹ˆ๊นŒ ๊ฐ‘์ž๊ธฐ ๋…ผ๋ฌธ์— ์“ธ ์ˆ˜ ์žˆ๋Š” ์ˆซ์ž๊ฐ€ ๋์–ด์š”. ์ง„์งœ ๋†€๋ž์Šต๋‹ˆ๋‹ค!” – ์‹ ๊ฒฝ๊ณผ ํŽ ๋กœ์šฐ ์‹ค์ œ ํ›„๊ธฐ ์ธ์šฉ.

๋Œ“๊ธ€

์ด ๋ธ”๋กœ๊ทธ์˜ ์ธ๊ธฐ ๊ฒŒ์‹œ๋ฌผ

ํžˆ๋ธŒ๋ฆฌ์ธ, ์ด์Šค๋ผ์—˜์ธ, ์œ ๋Œ€์ธ ์„ฑ๊ฒฝ ์† ์ด๋ฆ„์— ์ˆจ๊ฒจ์ง„ ์†Œ๋ฆ„ ๋‹๋Š” ๋น„๋ฐ€

์ž‘์€ ํ‹ˆ์ด ๋ฌด๋„ˆ๋œจ๋ฆฐ๋‹ค ์™œ ์šฐ๋ฆฌ๋Š” ‘์‚ฌ์†Œํ•œ ๋ถ„์—ด’์„ ๊ทน๋„๋กœ ๊ฒฝ๊ณ„ํ•ด์•ผ ํ•˜๋Š”๊ฐ€

์ž‘์€ ํ‹ˆ์ด ๋ฌด๋„ˆ๋œจ๋ฆฐ๋‹ค ์™œ ์„ฑ๊ฒฝ์€ ‘๋ถ„์—ด์˜ ์‹œ์ž‘’์„ ๊ทธ๋ ‡๊ฒŒ ๊ฒฝ๊ณ ํ•˜๋Š”๊ฐ€